News Sentiment

RFL sentiment intelligence

Rafael Holdings, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 54 relevant articles
Exchange NYSE United States
Sector Real Estate Market context
Industry Real Estate Services Read-through group
Latest close 2.73 Week of 19 Jun 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+21.9% over one week, +103.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Rafael Holdings Inc (RFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction 21.9% Price confirming higher
Trend fit Trend active 103.7% over four weeks
Fair value 64.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 34
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 9
TradingKey 7
The Manila Times 3
Quiver Quantitative 3
GlobeNewswire 2
Investing.com Canada 2
StockStory 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 21
Deals and strategy 6
Balance sheet 2
Guidance 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
ADVFN Direct company coverage

Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results

Rafael Holdings (NYSE: RFL) reported its fourth quarter and full fiscal year 2022 financial results, highlighting a net loss from continuing operations of $4.6 million for Q4 and $122.8 million for the full year. The company noted it plans to use $33 million from a real estate sa

Tone
Negative 38/100
Event
Earnings
Published
09 Apr 2026 06:40
Source
ADVFN
The Globe and Mail Direct company coverage

Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results

Rafael Holdings, Inc. reported its financial results for the second quarter and first six months of fiscal year 2026, ending January 31, 2026. The company experienced an increased net loss primarily due to the consolidation of Cyclo Therapeutics' expenses following its acquisitio

Tone
Positive 61/100
Event
Earnings
Published
17 Mar 2026 10:08
Source
The Globe and Mail
Stock Titan Direct company coverage

Rafael Holdings (NYSE: RFL) posts wider Q2 loss as Phase 3 NPC1 trial advances

Rafael Holdings (NYSE: RFL) reported a wider net loss of $6.4 million, or $0.13 per share, for Q2 fiscal 2026, compared to a $4.6 million loss a year prior, primarily due to increased R&D expenses following the acquisition of Cyclo Therapeutics. Despite the loss, the company's Ph

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Mar 2026 09:39
Source
Stock Titan
Stock Titan Direct company coverage

Safety board backs continued trial of Rafael drug for rare fatal disease

Rafael Holdings (NYSE: RFL) reported a Q2 fiscal 2026 net loss of $6.4 million ($0.13/share) and $37.8 million in cash and cash equivalents. The company's Data Monitoring Committee recommended continuing the Phase 3 TransportNPC study for Trappsol Cyclo, a drug for Niemann-Pick D

Tone
Neutral 50/100
Event
Balance sheet
Published
16 Mar 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Rafael Holdings (NYSE: RFL) ramps R&D spend, widens loss on $37.8M cash balance

Rafael Holdings (NYSE: RFL) reported a wider net loss of $16.2 million for the six months ended January 31, 2026, compared to $13.6 million in the prior year, primarily due to a significant increase in research and development expenses, which rose to $12.0 million from $2.3 milli

Tone
Negative 38/100
Event
Balance sheet
Published
16 Mar 2026 20:40
Source
Stock Titan
Intellectia AI Direct company coverage

CYTH Stock News Today | Earnings, Events & Price Alerts

This article provides recent news and events related to Cyclo Therapeutics (CYTH). Key updates include its merger with Rafael Holdings, preliminary positive data from its Phase 3 TransportNPC™ study for Niemann-Pick Disease Type C1, and an analyst downgrade following the merger a

Tone
Neutral 50/100
Event
Deals and strategy
Published
14 Mar 2026 10:51
Source
Intellectia AI
Stock Titan Direct company coverage

RFL SEC Filings - Rafael Holdings 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Rafael Holdings (RFL) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports. It details the company's biotechnology focus, financial activities, corporate governance, and insider transactions. The articl

Tone
Neutral 50/100
Event
Market update
Published
01 Mar 2026 05:52
Source
Stock Titan
Investing.com South Africa Direct company coverage

Rafael Holdings elects directors, approves equity plan amendment at annual meeting By Investing.com

Rafael Holdings (NYSE:RFL) held its annual meeting where shareholders elected six directors, ratified CohnReznick LLP as their independent accounting firm, and approved an amendment to the 2021 Equity Incentive Plan, increasing available Class B common stock by 1,000,000 shares.

Tone
Positive 64/100
Event
Market update
Published
15 Jan 2026 08:28
Source
Investing.com South Africa
Investing.com Nigeria Direct company coverage

Rafael Holdings elects directors, approves equity plan amendment at annual meeting

Rafael Holdings (NYSE:RFL) held its annual meeting where shareholders elected all director nominees to one-year terms and ratified CohnReznick LLP as their independent accounting firm. Additionally, stockholders approved an amendment to the 2021 Equity Incentive Plan, increasing

Tone
Neutral 50/100
Event
Market update
Published
12 Jan 2026 23:57
Source
Investing.com Nigeria
MarketBeat Direct company coverage

Short Interest in Rafael Holdings, Inc. (NYSE:RFL) Declines By 44.7%

Short interest in Rafael Holdings, Inc. (NYSE:RFL) significantly decreased by 44.7% in December, bringing the total to 40,257 shares, representing about 0.1% of shares outstanding. The biotechnology and real estate company currently holds an average analyst rating of "Sell" follo

Tone
Negative 30/100
Event
Analyst action
Published
27 Dec 2025 07:09
Source
MarketBeat
The Manila Times Direct company coverage

Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results

Rafael Holdings, Inc. reported its financial results for the first quarter of fiscal year 2026, ending October 31, 2025. The company announced a net loss of $9.8 million but expressed satisfaction with the progress of its pivotal Phase 3 TransportNPC™ study for Niemann-Pick Disea

Tone
Positive 65/100
Event
Earnings
Published
16 Dec 2025 10:08
Source
The Manila Times
Investing.com Canada Direct company coverage

Rafael Holdings issues warrants in connection with Cyclo Therapeutics merger

Rafael Holdings (NYSE:RFL) has issued 1,078,796 warrants, exercisable for 380,253 shares of its Class B common stock. These warrants, trading under the symbol RFL-WT on NYSE American, were issued as part of its merger with Cyclo Therapeutics. The warrants originated from outstand

Tone
Neutral 50/100
Event
Deals and strategy
Published
06 Dec 2025 12:09
Source
Investing.com Canada
TradingView Direct company coverage

Rafael Holdings Issues Warrants Post-Merger with Cyclo Therapeutics

Rafael Holdings announced on December 2, 2025, the issuance of 1,078,796 warrants following its merger with Cyclo Therapeutics. These warrants, exercisable for 380,253 shares of Class B common stock at $14.19 per share (RFL-WT), will expire on December 11, 2025. The conversion is

Tone
Neutral 50/100
Event
Deals and strategy
Published
03 Dec 2025 04:31
Source
TradingView
The Manila Times Direct company coverage

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

Rafael Holdings (NYSE: RFL) has released its financial results for the fourth quarter and full fiscal year ended July 31, 2025. The company highlighted the continued progress of its Phase 3 TransportNPC™ study for Niemann-Pick Disease Type C1 and its enhanced financial position f

Tone
Positive 64/100
Event
Earnings
Published
14 Nov 2025 12:08
Source
The Manila Times
Quiver Quantitative Direct company coverage

Rafael Holdings, Inc. Reports Continued Progress in Phase 3 Trial of Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 and Announces New COO

Rafael Holdings, Inc. announced continued progress in its Phase 3 clinical trial of Trappsol® Cyclo™ for Niemann-Pick Disease Type C1, with the Data Monitoring Committee recommending its continuation. The company also reported its fourth-quarter and full fiscal year 2025 financia

Tone
Positive 63/100
Event
Market update
Published
29 Oct 2025 20:34
Source
Quiver Quantitative